Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2012 Sep;15(3):342-9.
doi: 10.1007/s11102-011-0325-0.

Somatotroph pituitary adenoma with acromegaly and autosomal dominant polycystic kidney disease: SSTR5 polymorphism and PKD1 mutation

Affiliations
Case Reports

Somatotroph pituitary adenoma with acromegaly and autosomal dominant polycystic kidney disease: SSTR5 polymorphism and PKD1 mutation

Luis V Syro et al. Pituitary. 2012 Sep.

Abstract

A 39-year-old woman with autosomal dominant polycystic kidney disease (ADPKD) presented with acromegaly and a pituitary macroadenoma. There was a family history of this renal disorder. She had undergone surgery for pituitary adenoma 6 years prior. Physical examination disclosed bitemporal hemianopsia and elevation of both basal growth hormone (GH) 106 ng/mL (normal 0-5) and insulin-like growth factor (IGF-1) 811 ng/mL (normal 48-255) blood levels. A magnetic resonance imaging scan disclosed a 3.0 cm sellar and suprasellar mass with both optic chiasm compression and left cavernous sinus invasion. Pathologic, cytogenetic, molecular and in silico analysis was undertaken. Histologic, immunohistochemical and ultrastructural studies of the lesion disclosed a sparsely granulated somatotroph adenoma. Standard chromosome analysis on the blood sample showed no abnormality. Sequence analysis of the coding regions of PKD1 and PKD2 employing DNA from both peripheral leukocytes and the tumor revealed the most common PKD1 mutation, 5014_5015delAG. Analysis of the entire SSTR5 gene disclosed the variant c.142C>A (p.L48M, rs4988483) in the heterozygous state in both blood and tumor, while no pathogenic mutations were noted in the MEN1, AIP, p27Kip1 and SSTR2 genes. To our knowledge, this is the fourth reported case of a GH-producing pituitary adenoma associated with ADPKD, but the first subjected to extensive morphological, ultrastructural, cytogenetic and molecular studies. The physical proximity of the PKD1 and SSTR5 genes on chromosome 16 suggests a causal relationship between ADPKD and somatotroph adenoma.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Coronal (A) and sagittal (B) T1-weighted MRI with gadolinium enhancement demonstrating the 3-cm, enhancing sellar and suprasellar tumor compressing the optic chiasm and invading the left cavernous sinus. Postoperative coronal (C) and sagittal (D) T1-weighted MRI scan with gadolinium enhancement demonstrating residual tumor within the left cavernous sinus. An abdominal CT scan showing countless hepatic (E) and bilateral renal cysts (F).
Fig. 2
Fig. 2
(A) Light microscopic features of the pituitary adenoma. (B) Adenoma cells showing cytoplasmic immunopositivity for GH. (C) Few scattered adenoma cells show cytoplasmic immunopositivity for PRL. (D) Several tumor cell nuclei are immunopositive on MIB-1 stain. (E) Many adenoma cells contain cytoplasmic fibrous bodies immunopositive for low molecular weight keratin. (F) Electron microscopy reveals a sparsely granulated GH cell, adenoma with several large cytoplasmic fibrous bodies and few secretory granules. A, H&E 200x; B, 200x; C, 200x; D, 100x; E, 400x; F, 2500x.
Fig. 3
Fig. 3
Sequence analysis of PKD1. N, normal; M, patient blood DNA and T, patient tumor DNA showing the common PKD1 mutation c.5014_15delAG in the two patient samples
Fig. 4
Fig. 4
Sequence analysis of SSTR5 in blood (A) and tumor (B). The variant p.L48M is found in both patient samples.

Similar articles

Cited by

References

    1. Harris PC, Torres VE. Polycystic kidney disease. Annual review of medicine. 2009;60:321–337. - PMC - PubMed
    1. Torres VE, Harris PC. Autosomal dominant polycystic kidney disease: the last 3 years. Kidney international. 2009;76:149–168. - PMC - PubMed
    1. Melmed S. Medical progress: Acromegaly. The New England journal of medicine. 2006;355:2558–2573. - PubMed
    1. Melmed S. Acromegaly pathogenesis and treatment. The Journal of clinical investigation. 2009;119:3189–3202. - PMC - PubMed
    1. Fajfr R, Muller B, Diem P. Hypophyseal incidentaloma in a patient with autosomal dominant polycystic kidney disease. Praxis. 2002;91:1123–1126. - PubMed

Publication types

MeSH terms

Substances